Credent Connect N Care Limited IPO — Subscription & GMP
- Price band
- ₹179 – ₹189
- Lot size
- 600
- Issue size
- ₹67.36 Cr
- Bidding
- 13 Aug 2026 → 17 Aug 2026
- Allotment
- —
- Listing
- —
Schedule
Closing today- 13 Aug 2026IPO open date
- 17 Aug 2026IPO close date
- 18 Aug 2026Allotment date†
- 18 Aug 2026Funds unblock or debit†
- 20 Aug 2026Tentative listing date†
† Derived from the close date using the T+3 working-day timeline. The exchanges publish the open and close dates; the rest are indicative until confirmed, and exchange holidays are not accounted for.
Fundamentals
The business, its valuation and returnsBusiness Model of Credent Connect N Care Limited
Credent Connect N Care Limited operates as an integrated B2B healthcare operations partner, specializing in specialized supply chain and logistics solutions for the medical and diagnostic sectors. Originally established in 2015 as a cold-chain logistics startup, it has evolved to provide end-to-end operational support to diagnostic laboratories, IVD companies, hospitals, and pharmaceutical firms.
- Core Offerings: The company’s services focus heavily on pre-analytical and supply-chain operations. This includes the temperature-controlled and Turnaround Time (TAT) sensitive transportation of diagnostic samples (such as blood samples) and reagents. Additionally, it provides extensive workforce solutions by deploying trained phlebotomists for home sample collection and stationing paramedical staff and laboratory technicians directly at client hospitals and clinics.
- Technology Integration: To support its logistics capabilities, Credent Connect utilizes advanced technologies, including IoT-based tracking devices and real-time temperature monitoring, ensuring the integrity of critical medical specimens during transit.
- Revenue Generation: The company earns its revenue through B2B service-level contracts with healthcare institutions, acting as a back-end partner that manages logistical friction and streamlines diagnostic operations. However, its business model relies heavily on its top 10 customers and the broader diagnostic industry, exposing it to risks related to contract renewals and the continuous need to retain a highly skilled, geographically dispersed workforce.
| Metric | Pre-issue | Post-issue |
|---|---|---|
| EPS | ₹13.95 | — |
| P/E ratio | 13.55× | — |
Promoter holding pre/post issue is in the offer document but we do not yet extract it. Left blank rather than estimated.
Read from the company’s offer document filed with SEBI. Figures are the latest reported financial year, as restated in that filing.
Figures are as reported and not independently audited, and are read 6 d ago.
Grey market premium
Unofficial · not from any exchangeUpper band ₹189 + GMP ₹47 implies a listing around ₹236 (+24.87%). That is what the grey market is pricing, not a forecast.
Subscription status
Live from NSE · fetched 17 min ago| Category | Shares offered | Shares bid for | Subscribed |
|---|---|---|---|
| 1Qualified Institutional Buyers(QIBs) | — | 12.36 Cr | 0.00× |
| 1(a)Foreign Institutional Investors(FIIs) | — | 1.85 Cr | — |
| 1(b)Domestic Financial Institutions(Banks/ Financial Institutions(FIs)/ Insurance Companies) | — | 1.78 Cr | — |
| 1(c)Mutual funds | — | 27.21 L | — |
| 1(d)Others | — | 8.46 Cr | — |
| 2Non Institutional Investors | — | 15.39 Cr | 0.00× |
| 2.1Non Institutional Investors(Bid amount of more than Ten Lakh Rupees) | — | 12.09 Cr | 0.00× |
| 2.1(a)Corporates | — | 22.13 L | — |
| 2.1(b)Individuals(Other than RIIs) | — | 11.62 Cr | — |
| 2.1(b)Individuals(IND category bidding for more than 2 Lots) | — | 11.62 Cr | — |
| 2.2Non Institutional Investors(Bid amount of more than Two Lakh Rupees upto Ten Lakh Rupees) | — | 3.30 Cr | 0.00× |
| 3Individual Investors (IND category bidding for 2 Lots) | — | 23.00 Cr | — |
| Total | — | 27.75 Cr | 0.00× |
Source: NSE issue information
Anchor investors
From NSE's anchor allocation filingAnchor investors are institutions allotted shares one working day before public bidding opens, in exchange for a lock-in. Up to 60% of the QIB portion can go to them, which reduces the QIB shares left for everyone else — and their participation is widely read as a confidence signal.
Anchor allocation report (NSE)
This issue’s anchor letter was filed as a scanned image with no text layer, so the allocation table cannot be read without OCR. We link the filing rather than publish figures we cannot verify.
Allotment status
Issue details
- Price band
- ₹179 – ₹189
- Lot size
- 600 shares
- Min. bid quantity
- —
- Face value
- ₹10.00
- Tick size
- ₹1.00
- Shares offered
- 35.64 L
- Issue size
- ₹67.36 Cr
- Max bid · QIB
- 33.12 L
- Max bid · NII
- 23.64 L
Timeline & process
- Bidding opens
- 13 Aug 2026
- Bidding closes
- 17 Aug 2026
- Bidding hours
- 10.00 a.m. to 5.00 p.m. (Bidding Timings on Issue Closure upto 4:00 P.M.)
- UPI mandate cutoff
- 17-August-2026 (upto 5:00 PM) The cut-off time for UPI mandate acceptance is 05:00 PM on last day of IPO bidding. Further bids with confirmed status of mandate amount blocked (RC100) shall be considered as valid applications and hence investors are advised to submit their UPI applications in IPO well in advance to avoid any last minute technical/systemic constraints that may hamper their ability to participate in IPOs by successfully accepting the mandate.
- Allotment
- —
- Listing
- —
Intermediaries
- Registrar
- Kfin Technologies Limited
- Sponsor bank
- Kotak Mahindra Bank Limited
- Lead managers
- Hem Securities Limited